Dec. 30 (UPI) -- Chinese drugmaker Sinopharm said Wednesday that interim clinical trial results have shown that one of two COVID-19 vaccines it's testing is almost 80% effective in blocking the coronavirus.
The results were announced and released by the Beijing Institute of Biological Products, a subsidiary of state-owned Sinopharm.